Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Mouse monoclonal [3F8 ] to smooth muscle Myosin heavy chain I ( Abpromise for all tested applications). entrezGeneID: 4629 SwissProtID: P35749...
Rabbit polyclonal to CAMK 1D beta ( Abpromise for all tested applications). entrezGeneID: 57118 SwissProtID: Q5SQQ7...
Request Info...
Biology Products:(Date:5/21/2013)... NANONEX CORPORATION, a pioneer and ... announced the successful delivery and installation of a ... to a major Japanese manufacturing company. ... advanced nanoimprint lithography tool that has the ability ... sizes and types. Based on Nanonex inventions and ...
(Date:5/21/2013)... SoundConnect is pleased to announce the release of ... Canada. Lync is the next generation of ... organizations to collaborate and communicate much more easily and ... United States. With the progressive rollout of Lync in ... SoundConnect now offers a complete Microsoft Lync solution for ...
(Date:5/20/2013)... 20, 2013 , Collaboration ... Service (ARS) in treatment of mastitis ... Trials to begin in the second half 2013 ... company Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) ... Agricultural Research Service (ARS) to develop and trial products ...
(Date:5/20/2013)... Today, at the American Psychiatric Association (APA) ... James McGough , M.D., M.S., principal investigator ... for Neuroscience and Human Behavior and David ... of California Los Angeles (UCLA), and director of clinical ... ADHD at UCLA, presented the results of a Phase ...
Breaking Biology Technology:Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3Phosphagenics Signs Research Agreement with the Agricultural Research Service 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Biology NavigationMedical Navigation